Introduction
Endoscopic laser cordectomy is a minimally invasive surgical technique that utilizes laser energy delivered through an endoscope to remove or ablate diseased vocal fold tissue. The procedure is performed transorally or transnasally, allowing direct visualization of the laryngeal structures while preserving surrounding anatomy. It is commonly employed to treat benign lesions such as polyps, nodules, cysts, and papillomas, as well as early malignant lesions confined to the vocal folds. The combination of precise laser targeting and endoscopic guidance results in reduced postoperative pain, faster recovery, and lower rates of postoperative scarring compared with traditional open microlaryngoscopy.
History and Development
The evolution of endoscopic laser cordectomy began in the mid‑20th century with the advent of laser technology in medicine. The first laryngeal laser procedures were performed using the CO₂ laser in the 1960s, which offered excellent tissue vaporization and coagulation properties. Early adopters used the laser in open laryngeal surgery; however, the limitations of exposure and postoperative morbidity prompted exploration of endoscopic delivery systems. In the 1970s, flexible fiberoptic scopes capable of transmitting laser energy were developed, enabling the first true endoscopic laser interventions. Subsequent refinements in laser safety, optics, and endoscope design led to widespread clinical acceptance during the 1980s and 1990s.
Throughout the late 20th and early 21st centuries, multiple laser modalities were introduced, including the Nd:YAG, KTP, and diode lasers, each with distinct tissue interaction profiles. The emergence of high‑definition endoscopic cameras and image‑enhancement techniques further improved visualization, allowing surgeons to perform more precise tissue removal. Concurrent advances in anesthesia protocols, such as local anesthetic injection with topical lidocaine, reduced the need for general anesthesia in many cases, thereby expanding the applicability of endoscopic laser cordectomy to outpatient settings.
Current practice incorporates a range of lasers and endoscopic systems, tailored to the specific pathology and surgeon preference. Evidence from randomized controlled trials has demonstrated that endoscopic laser cordectomy offers comparable oncologic outcomes to open surgery for early glottic cancers while reducing operative morbidity. The procedure remains a cornerstone of contemporary laryngeal microsurgery, with ongoing research focusing on optimizing laser parameters, expanding indications, and integrating adjunctive technologies such as augmented reality guidance.
Key Concepts and Principles
Successful endoscopic laser cordectomy hinges on several foundational principles. First, the choice of laser wavelength dictates tissue absorption characteristics, depth of penetration, and coagulation potential. CO₂ lasers emit at 10,600 nm and are strongly absorbed by water, producing precise vaporization with minimal collateral damage. Nd:YAG lasers, at 1,064 nm, penetrate deeper but require careful titration to avoid excessive thermal spread. Diode and KTP lasers occupy intermediate positions, offering balanced cutting and coagulation effects.
Second, the delivery system - whether a rigid or flexible fiberoptic bundle - must maintain consistent energy transmission while allowing maneuverability within the laryngeal cavity. Fiber diameter, numerical aperture, and tip design influence spot size and power density, which are critical for achieving the desired surgical effect. Third, endoscopic visualization must provide high‑resolution, wide‑field imagery, often supplemented by color enhancement or narrow‑band imaging to delineate vascular patterns and lesion boundaries.
Finally, surgical technique emphasizes controlled application of laser energy, incremental tissue removal, and real‑time assessment of hemostasis. Surgeons typically start with low power settings, gradually increasing as the tissue response becomes apparent. Continuous irrigation or saline lavage during the procedure can aid in cooling, reducing the risk of inadvertent thermal injury to adjacent structures such as the vocal processes or arytenoids.
Indications and Contraindications
Endoscopic laser cordectomy is indicated for a variety of vocal fold lesions. Benign conditions commonly treated include vocal fold polyps, cysts, granulomas, and papillomatosis. The procedure offers effective removal with minimal disruption to the mucosal layer, preserving phonatory function. For early glottic carcinoma - classified as T1a (confined to one vocal fold) or T1b (involving both folds but without subglottic extension) - laser cordectomy provides oncologic control comparable to open partial laryngectomy while preserving laryngeal structure.
Contraindications arise when lesions extend beyond the vocal folds, involve the subglottic space, or exhibit extensive cartilage invasion. In such cases, open surgical approaches or advanced modalities like transoral laser microsurgery with more extensive resection may be required. Additional contraindications include severe tracheal stenosis, uncontrolled systemic disease precluding anesthesia, and patient refusal of laser treatment due to prior adverse events.
Specific preoperative assessments - such as fiberoptic laryngoscopy, high‑resolution computed tomography, and laryngeal electromyography - inform the surgical plan. Patients with active infections, bleeding disorders, or allergy to local anesthetics require careful evaluation and potential optimization before proceeding.
Procedure Details
The standard workflow for endoscopic laser cordectomy comprises preoperative preparation, anesthesia, laser activation, lesion excision, and postoperative care. Prior to the operation, the patient undergoes thorough evaluation of vocal fold pathology via laryngoscopy. The chosen laser and fiberoptic system are calibrated according to the lesion’s size and depth. Local anesthesia is administered through intralaryngeal injection of lidocaine and topical application to the mucosa. General anesthesia may be employed for patients requiring extended procedures or those with significant anxiety.
During the operation, the endoscope is introduced transorally or transnasally, depending on surgeon preference and patient anatomy. The laser fiber is positioned at the target site under direct visualization. The surgeon initiates energy delivery at a low power setting - typically between 5–10 watts for CO₂ lasers - and monitors the tissue response. As the lesion is vaporized, the fiber tip is advanced incrementally, ensuring complete removal while preserving adjacent normal mucosa.
Hemostasis is achieved through continuous laser coagulation or, when necessary, by applying a cottonoid soaked in saline and compressing the area. After excision, the surgeon assesses the vocal fold surface for residual tissue or scar formation. The endoscope is then removed, and the patient is observed for airway compromise or bleeding.
Equipment and Technology
Laser Types
- CO₂ Laser (10,600 nm): Provides precise vaporization with minimal penetration, ideal for superficial lesions.
- Nd:YAG Laser (1,064 nm): Offers deeper tissue penetration, suitable for submucosal pathology but requires careful control.
- Diode Laser (800–1,050 nm): Combines cutting and coagulation with a narrower beam, used for benign lesions and early cancers.
- KTP Laser (532 nm): Highly absorbed by hemoglobin, useful for vascular lesions and providing excellent hemostasis.
Endoscopic Systems
- Rigid Microlaryngoscopes: Provide a stable platform for fiber insertion and precise laser delivery.
- Flexible Fiberoptic Scopes: Allow greater maneuverability, especially in patients with limited mouth opening or nasal pathology.
- High‑Definition Cameras: Offer improved resolution and color fidelity, aiding in lesion delineation.
- Image‑Enhancement Technologies: Narrow‑band imaging and optical coherence tomography can reveal vascular patterns and mucosal integrity.
Modern laser generators incorporate safety interlocks, real‑time power monitoring, and programmable pulse sequences. Surgeons often tailor the laser settings - power, duration, spot size - to the individual patient’s tissue characteristics, achieving optimal cutting with minimal collateral damage.
Outcomes and Efficacy
Clinical studies demonstrate that endoscopic laser cordectomy yields favorable outcomes across benign and malignant indications. In benign disease, recurrence rates range from 5–15 % over a 5‑year follow‑up, largely dependent on the initial pathology and completeness of excision. Functional voice outcomes, measured by parameters such as maximum phonation time, fundamental frequency, and acoustic quality, typically improve within weeks postoperatively.
For early glottic cancer, series report 5‑year local control rates between 80 % and 95 %, comparable to open partial laryngectomy. The morbidity profile is superior: patients experience less postoperative pain, shorter hospital stays (often outpatient), and quicker return to daily activities. Vocal outcomes after laser cordectomy for T1 glottic carcinoma are similar to those after open surgery, with the added benefit of preserving laryngeal sensitivity.
Long‑term studies also indicate that repeated laser treatments for recalcitrant lesions are feasible without significant compromise to vocal fold integrity. However, cumulative thermal exposure may increase the risk of scarring and dysphonia over time, underscoring the importance of meticulous technique and follow‑up surveillance.
Complications and Management
While generally safe, endoscopic laser cordectomy can be associated with several complications. Common issues include postoperative bleeding, infection, edema, and transient vocal fold paralysis. Bleeding is usually controlled intraoperatively through laser coagulation; residual oozing may be managed with topical hemostatic agents such as fibrin glue or sutures if necessary. Infection risk is mitigated by maintaining sterile technique and, when appropriate, prescribing postoperative antibiotics.
Scarring remains a principal concern, particularly when extensive tissue is removed or when thermal injury extends beyond the mucosa. Scar formation can impair vocal fold vibration, leading to hoarseness or dysphonia. Early identification of scarring allows for timely intervention with speech therapy, micro‑staging, or, in severe cases, laser re‑excision. Vocal fold paralysis, typically due to recurrent laryngeal nerve irritation, is rare but may necessitate laryngeal framework surgery or voice therapy to restore function.
Rare but serious complications include airway compromise from edema or hemorrhage and inadvertent cartilage injury, which may require emergent airway management or reconstructive procedures. Adherence to safety protocols, including continuous monitoring of airway patency and hemodynamic status, reduces the likelihood of catastrophic events.
Comparison with Alternative Techniques
Endoscopic laser cordectomy is one of several modalities for treating vocal fold lesions. Alternatives include cold instrument microlaryngoscopy, cryotherapy, radiofrequency ablation, and open partial laryngectomy. Each technique offers distinct advantages and limitations.
Cold instrument surgery provides direct tactile feedback and is useful for extensive lesions but often requires larger incisions and may lead to greater postoperative pain. Cryotherapy offers tissue destruction with minimal thermal spread but requires longer application times and may result in slower healing. Radiofrequency ablation provides rapid tissue coagulation but can produce uneven depth of effect, making precise control challenging.
Open partial laryngectomy, performed via external approaches such as the horizontal or vertical laryngotomy, allows for wide exposure and removal of larger tumors. However, it carries higher morbidity, including increased risk of postoperative edema, scarring, and longer recovery periods. Comparative studies demonstrate that for T1 glottic cancers, endoscopic laser cordectomy and open surgery provide equivalent oncologic outcomes, but laser cordectomy achieves better postoperative voice quality and reduced hospitalization time.
In practice, the choice of technique depends on lesion characteristics, surgeon expertise, equipment availability, and patient preference. Endoscopic laser cordectomy remains the preferred approach for many early-stage lesions due to its minimally invasive nature and favorable functional outcomes.
Future Directions
Ongoing research seeks to refine endoscopic laser cordectomy through technological innovation and evidence‑based practice. Emerging laser platforms, such as high‑power diode systems with ultrafast pulsing, promise enhanced precision and reduced collateral damage. Integration of real‑time imaging modalities - including optical coherence tomography and intraoperative ultrasound - could enable surgeons to visualize subsurface pathology and tailor energy delivery more accurately.
Advancements in robotics and computer‑assisted surgery may provide augmented dexterity, especially in patients with limited mouth opening or challenging anatomy. For instance, robotic endoscopic platforms could offer tremor‑free manipulation of the laser fiber and endoscope, improving reproducibility across surgeons.
From a clinical standpoint, large multicenter registries and prospective trials are needed to quantify long‑term voice outcomes, recurrence rates, and quality‑of‑life metrics. The development of standardized laser protocols, including optimal power settings and treatment intervals, will facilitate consistency in practice and enable meaningful comparisons across studies.
Finally, patient‑centric research focusing on shared decision‑making, preoperative counseling, and postoperative voice rehabilitation will help ensure that endoscopic laser cordectomy not only addresses the underlying pathology but also aligns with patients’ functional goals and expectations.
No comments yet. Be the first to comment!